Literature DB >> 15945371

Selection of protein epitopes for antibody production.

Mats Lindskog1, Johan Rockberg, Mathias Uhlén, Fredrik Sterky.   

Abstract

Protein functional analysis in the post-genomic era is a huge task that has to be approached by different methods in parallel. The use of protein-specific antibodies in conjunction with tissue microarrays has proven to be one important technology. In this study, we present a strategy for the optimized design of protein subfragments for subsequent antibody production. The fragments are selected based on a principle of lowest sequence similarity to other human proteins, optimally to generate antibodies with high selectivity. Furthermore, the fragments should have properties optimized for efficient protein production in Escherichia coli. The strategy has been implemented in Bishop, which is a Java-based software enabling the high-throughput production of protein fragments. Bishop allows for the avoidance of certain restriction enzyme sites, transmembrane regions, and signal peptides. A Basic Local Alignment Search Tool (BLAST) scanning procedure permits the selection of fragments of a selected size with a minimal sequence similarity to other proteins. The software and the strategy were evaluated on a human test data set and verified to fulfill the requested criteria.

Entities:  

Mesh:

Year:  2005        PMID: 15945371     DOI: 10.2144/05385ST02

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  15 in total

1.  NHLBI-AbDesigner: an online tool for design of peptide-directed antibodies.

Authors:  Trairak Pisitkun; Jason D Hoffert; Fahad Saeed; Mark A Knepper
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-28       Impact factor: 4.249

2.  The epitope space of the human proteome.

Authors:  Lisa Berglund; Jorge Andrade; Jacob Odeberg; Mathias Uhlén
Journal:  Protein Sci       Date:  2008-04       Impact factor: 6.725

3.  Prediction of antibody response using recombinant human protein fragments as antigen.

Authors:  Johan Rockberg; Mathias Uhlén
Journal:  Protein Sci       Date:  2009-11       Impact factor: 6.725

4.  A validated collection of mouse monoclonal antibodies to human glycosyltransferases functioning in mucin-type O-glycosylation.

Authors:  Catharina Steentoft; Zhang Yang; Shengjun Wang; Tongzhong Ju; Malene B Vester-Christensen; María F Festari; Sarah L King; Kelley Moremen; Ida S B Larsen; Christoffer K Goth; Katrine T Schjoldager; Lars Hansen; Eric P Bennett; Ulla Mandel; Yoshiki Narimatsu
Journal:  Glycobiology       Date:  2019-08-20       Impact factor: 4.313

5.  Characterization of Epidermal Lipoxygenase Expression in Normal Human Skin and Tissue-Engineered Skin Substitutes.

Authors:  Carolyne Simard-Bisson; Lorraine Andrée Parent; Véronique J Moulin; Bernard Fruteau de Laclos
Journal:  J Histochem Cytochem       Date:  2018-07-09       Impact factor: 2.479

6.  Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1.

Authors:  Cordula Klockenbusch; Juergen Kast
Journal:  J Biomed Biotechnol       Date:  2010-06-28

7.  Tissue profiling of the mammalian central nervous system using human antibody-based proteomics.

Authors:  Jan Mulder; Erik Björling; Kalle Jonasson; Henrik Wernérus; Sophia Hober; Tomas Hökfelt; Mathias Uhlén
Journal:  Mol Cell Proteomics       Date:  2009-04-07       Impact factor: 5.911

8.  Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies.

Authors:  Johan Rockberg; Jochen M Schwenk; Mathias Uhlén
Journal:  Mol Oncol       Date:  2009-01-31       Impact factor: 6.603

9.  Generation of a Polyclonal Antibody against the Mouse Metal Transporter ZIP8.

Authors:  Guojun Wei; Yuze Wu; Ningning Zhao
Journal:  Antibodies (Basel)       Date:  2021-04-21

10.  A lateral flow protein microarray for rapid and sensitive antibody assays.

Authors:  Jesper Gantelius; Tarek Bass; Ronald Sjöberg; Peter Nilsson; Helene Andersson-Svahn
Journal:  Int J Mol Sci       Date:  2011-11-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.